BMT Tandem Meeting</br>Presentation Preliminary Results from the AdVise Study Evaluating Brincidofovir (BCV, CMX001) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection

Feb 12, 2015 at 12:00 AM EST

Speaker

Michael Grimley, MD